IDBD: Infectious Disease Biomarker Database

Biomarkers enable early diagnosis, guide molecularly targeted therapy and monitor the activity and therapeutic responses across a variety of diseases. Despite intensified interest and research, however, the overall rate of development of novel biomarkers has been falling. Moreover, no solution is yet available that efficiently retrieves and processes biomarker information pertaining to infectious diseases. Infectious Disease Biomarker Database (IDBD) is one of the first efforts to build an easily accessible and comprehensive literature-derived database covering known infectious disease biomarkers. IDBD is a community annotation database, utilizing collaborative Web 2.0 features, providing a convenient user interface to input and revise data online. It allows users to link infectious diseases or pathogens to protein, gene or carbohydrate biomarkers through the use of search tools. It supports various types of data searches and application tools to analyze sequence and structure features of potential and validated biomarkers. Currently, IDBD integrates 611 biomarkers for 66 infectious diseases and 70 pathogens. It is publicly accessible at http://biomarker.cdc.go.kr and http://biomarker.korea.ac.kr.

[1]  Danny Chuon,et al.  Gastric Cancer (Biomarkers) Knowledgebase (GCBKB): A Curated and Fully Integrated Knowledgebase of Putative Biomarkers Related to Gastric Cancer , 2006, Biomarker insights.

[2]  Tatiana A. Tatusova,et al.  Entrez Gene: gene-centered information at NCBI , 2004, Nucleic Acids Res..

[3]  Susie Stephens,et al.  Oracle Database 10g: a platform for BLAST search and Regular Expression pattern matching in life sciences , 2004, Nucleic Acids Res..

[4]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[5]  Monya Baker,et al.  In biomarkers we trust? , 2005, Nature Biotechnology.

[6]  Janet M. Thornton,et al.  PDBsum more: new summaries and analyses of the known 3D structures of proteins and nucleic acids , 2004, Nucleic Acids Res..

[7]  Christophe Combet,et al.  Geno3D: automatic comparative molecular modelling of protein , 2002, Bioinform..

[8]  Paul G Thomas,et al.  Influenza and the challenge for immunology , 2006, Nature Immunology.

[9]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[10]  Jonathan H. Epstein,et al.  Bats Are Natural Reservoirs of SARS-Like Coronaviruses , 2005, Science.

[11]  B. Kramer,et al.  Trends in biomarker research for cancer detection. , 2001, The Lancet. Oncology.

[12]  M.D. Wang,et al.  An Integrated Cancer Biomarker Information System , 2005, 2005 IEEE Engineering in Medicine and Biology 27th Annual Conference.

[13]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[14]  Collin M. Stultz,et al.  Structural analysis based on state‐space modeling , 1993, Protein science : a publication of the Protein Society.

[15]  A. Fauci,et al.  The challenge of emerging and re-emerging infectious diseases , 2004, Nature.

[16]  P. Mendola,et al.  Development of a biomarkers database for the National Children's Study. , 2005, Toxicology and applied pharmacology.

[17]  Steven A Carr,et al.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility , 2006, Nature Biotechnology.

[18]  Peter E. Hilsenrath,et al.  The World Health Report 2000 , 2002 .

[19]  Franco M Buonaguro,et al.  Introducing Infectious Agents and Cancer , 2006, Infectious Agents and Cancer.